Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same
The invention relates to the technical fields of biology, pharmacology and medicine. The invention is suitable for use in particular in the human and animal health fields. More specifically, the invention relates to the use of a cAMP modulator in the preparation of compositions that are intended for the prevention or treatment of peripheral neuropathies. The invention further relates to tools and kits to prepare the aforementioned compositions.
1. A method for the treatment of Charcot-Marie-Tooth disease comprising administering to a subject affected by or presenting a risk of developing such disease, a composition consisting essentially of a therapeutically effective amount of at least one therapeutically active ingredient selected from the group consisting of ascorbic acid, ascorbyl palmitate, dipalmitate L-ascorbate, a glycosylated ascorbic acid, a mannosylated ascorbic acid, a fructosylated ascorbic acid, a fucosylated ascorbic acid, a galactosylated ascorbic acid, a N-acetylglucosaminated ascorbic acid, a N-acetylmuramic ascorbic acid, a metal salt of phosphorylated ascorbic acid, an alkaline metal ascorbyl phosphate, an alkaline earth metal ascorbyl phosphate, a transition metal ascorbyl phosphate, an ascorbyl sulphate, ascorbyl-2 glucoside, 2-O-alpha-D-glucopyranosyl ascorbic acid, 6-O-beta-D-galactopyranosyl L-ascorbic acid, and magnesium ascorbyl phosphate.
2. The method according to claim 1 , wherein said Charcot-Marie-Tooth disease is type I Charcot-MarieTooth disease (CMTI).
3. The method according to claim 1 , wherein the ascorbic acid is selected from a natural vitamin C and a synthetic vitamin C.
4. The method according to claim 1 , wherein the at least one therapeutically active ingredient is administered to a human in need of such treatment in unit doses comprising from 1 g to 6 grams of the at least one therapeutically active ingredient.